NEW PROSPECTS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATIO AND CORONARY ARTERY STENTS: DABIGATRAN POTENTIAL

• Κύριοι συγγραφείς: M. Yu. GILYAROV (Συγγραφέας), E. V. KONSTANTINOVA (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: «REMEDIUM GROUP» Ltd., 2017-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

After percutaneous coronary intervention, patients receive double antiplatelet therapy for several months, which includes acetylsalicylic acid and a P2Y12 receptor inhibitor. In most cases, managing the patients with the atrial fibrillation requires adding an anticoagulant drug to the antiplatelet t...